Luseogliflozin Market, Global Outlook and Forecast 2022-2028

July 2024 | 78 pages | ID: LA9E91E049A5EN
Market Monitor Global

Abstracts

Luseogliflozin (trade name Lusefi) is a pharmaceutical drug used for the treatment of type 2 diabetes mellitus.

This report contains market size and forecasts of Luseogliflozin in global, including the following market information:

Global Luseogliflozin Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Luseogliflozin Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Luseogliflozin companies in 2021 (%)

The global Luseogliflozin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

2.5mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Luseogliflozin include Taisho Toyama, Novartis, Mitsubishi Tanabe Pharma and CR Double-Crane, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Luseogliflozin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Luseogliflozin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Luseogliflozin Market Segment Percentages, by Type, 2021 (%)

• 2.5mg
• 5mg

Global Luseogliflozin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Luseogliflozin Market Segment Percentages, by Application, 2021 (%)

• Diabetes
• Heart Disease
• Periodontitis

Global Luseogliflozin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Luseogliflozin Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Luseogliflozin revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Luseogliflozin revenues share in global market, 2021 (%)

Key companies Luseogliflozin sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Luseogliflozin sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Taisho Toyama
• Novartis
• Mitsubishi Tanabe Pharma
• CR Double-Crane

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Luseogliflozin Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Luseogliflozin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LUSEOGLIFLOZIN OVERALL MARKET SIZE

2.1 Global Luseogliflozin Market Size: 2021 VS 2028
2.2 Global Luseogliflozin Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Luseogliflozin Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Luseogliflozin Players in Global Market
3.2 Top Global Luseogliflozin Companies Ranked by Revenue
3.3 Global Luseogliflozin Revenue by Companies
3.4 Global Luseogliflozin Sales by Companies
3.5 Global Luseogliflozin Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Luseogliflozin Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Luseogliflozin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Luseogliflozin Players in Global Market
  3.8.1 List of Global Tier 1 Luseogliflozin Companies
  3.8.2 List of Global Tier 2 and Tier 3 Luseogliflozin Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Luseogliflozin Market Size Markets, 2021 & 2028
  4.1.2 2.5mg
  4.1.3 5mg
4.2 By Type - Global Luseogliflozin Revenue & Forecasts
  4.2.1 By Type - Global Luseogliflozin Revenue, 2017-2022
  4.2.2 By Type - Global Luseogliflozin Revenue, 2023-2028
  4.2.3 By Type - Global Luseogliflozin Revenue Market Share, 2017-2028
4.3 By Type - Global Luseogliflozin Sales & Forecasts
  4.3.1 By Type - Global Luseogliflozin Sales, 2017-2022
  4.3.2 By Type - Global Luseogliflozin Sales, 2023-2028
  4.3.3 By Type - Global Luseogliflozin Sales Market Share, 2017-2028
4.4 By Type - Global Luseogliflozin Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Luseogliflozin Market Size, 2021 & 2028
  5.1.2 Diabetes
  5.1.3 Heart Disease
  5.1.4 Periodontitis
5.2 By Application - Global Luseogliflozin Revenue & Forecasts
  5.2.1 By Application - Global Luseogliflozin Revenue, 2017-2022
  5.2.2 By Application - Global Luseogliflozin Revenue, 2023-2028
  5.2.3 By Application - Global Luseogliflozin Revenue Market Share, 2017-2028
5.3 By Application - Global Luseogliflozin Sales & Forecasts
  5.3.1 By Application - Global Luseogliflozin Sales, 2017-2022
  5.3.2 By Application - Global Luseogliflozin Sales, 2023-2028
  5.3.3 By Application - Global Luseogliflozin Sales Market Share, 2017-2028
5.4 By Application - Global Luseogliflozin Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Luseogliflozin Market Size, 2021 & 2028
6.2 By Region - Global Luseogliflozin Revenue & Forecasts
  6.2.1 By Region - Global Luseogliflozin Revenue, 2017-2022
  6.2.2 By Region - Global Luseogliflozin Revenue, 2023-2028
  6.2.3 By Region - Global Luseogliflozin Revenue Market Share, 2017-2028
6.3 By Region - Global Luseogliflozin Sales & Forecasts
  6.3.1 By Region - Global Luseogliflozin Sales, 2017-2022
  6.3.2 By Region - Global Luseogliflozin Sales, 2023-2028
  6.3.3 By Region - Global Luseogliflozin Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Luseogliflozin Revenue, 2017-2028
  6.4.2 By Country - North America Luseogliflozin Sales, 2017-2028
  6.4.3 US Luseogliflozin Market Size, 2017-2028
  6.4.4 Canada Luseogliflozin Market Size, 2017-2028
  6.4.5 Mexico Luseogliflozin Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Luseogliflozin Revenue, 2017-2028
  6.5.2 By Country - Europe Luseogliflozin Sales, 2017-2028
  6.5.3 Germany Luseogliflozin Market Size, 2017-2028
  6.5.4 France Luseogliflozin Market Size, 2017-2028
  6.5.5 U.K. Luseogliflozin Market Size, 2017-2028
  6.5.6 Italy Luseogliflozin Market Size, 2017-2028
  6.5.7 Russia Luseogliflozin Market Size, 2017-2028
  6.5.8 Nordic Countries Luseogliflozin Market Size, 2017-2028
  6.5.9 Benelux Luseogliflozin Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Luseogliflozin Revenue, 2017-2028
  6.6.2 By Region - Asia Luseogliflozin Sales, 2017-2028
  6.6.3 China Luseogliflozin Market Size, 2017-2028
  6.6.4 Japan Luseogliflozin Market Size, 2017-2028
  6.6.5 South Korea Luseogliflozin Market Size, 2017-2028
  6.6.6 Southeast Asia Luseogliflozin Market Size, 2017-2028
  6.6.7 India Luseogliflozin Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Luseogliflozin Revenue, 2017-2028
  6.7.2 By Country - South America Luseogliflozin Sales, 2017-2028
  6.7.3 Brazil Luseogliflozin Market Size, 2017-2028
  6.7.4 Argentina Luseogliflozin Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Luseogliflozin Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Luseogliflozin Sales, 2017-2028
  6.8.3 Turkey Luseogliflozin Market Size, 2017-2028
  6.8.4 Israel Luseogliflozin Market Size, 2017-2028
  6.8.5 Saudi Arabia Luseogliflozin Market Size, 2017-2028
  6.8.6 UAE Luseogliflozin Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Taisho Toyama
  7.1.1 Taisho Toyama Corporate Summary
  7.1.2 Taisho Toyama Business Overview
  7.1.3 Taisho Toyama Luseogliflozin Major Product Offerings
  7.1.4 Taisho Toyama Luseogliflozin Sales and Revenue in Global (2017-2022)
  7.1.5 Taisho Toyama Key News
7.2 Novartis
  7.2.1 Novartis Corporate Summary
  7.2.2 Novartis Business Overview
  7.2.3 Novartis Luseogliflozin Major Product Offerings
  7.2.4 Novartis Luseogliflozin Sales and Revenue in Global (2017-2022)
  7.2.5 Novartis Key News
7.3 Mitsubishi Tanabe Pharma
  7.3.1 Mitsubishi Tanabe Pharma Corporate Summary
  7.3.2 Mitsubishi Tanabe Pharma Business Overview
  7.3.3 Mitsubishi Tanabe Pharma Luseogliflozin Major Product Offerings
  7.3.4 Mitsubishi Tanabe Pharma Luseogliflozin Sales and Revenue in Global (2017-2022)
  7.3.5 Mitsubishi Tanabe Pharma Key News
7.4 CR Double-Crane
  7.4.1 CR Double-Crane Corporate Summary
  7.4.2 CR Double-Crane Business Overview
  7.4.3 CR Double-Crane Luseogliflozin Major Product Offerings
  7.4.4 CR Double-Crane Luseogliflozin Sales and Revenue in Global (2017-2022)
  7.4.5 CR Double-Crane Key News

8 GLOBAL LUSEOGLIFLOZIN PRODUCTION CAPACITY, ANALYSIS

8.1 Global Luseogliflozin Production Capacity, 2017-2028
8.2 Luseogliflozin Production Capacity of Key Manufacturers in Global Market
8.3 Global Luseogliflozin Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 LUSEOGLIFLOZIN SUPPLY CHAIN ANALYSIS

10.1 Luseogliflozin Industry Value Chain
10.2 Luseogliflozin Upstream Market
10.3 Luseogliflozin Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Luseogliflozin Distributors and Sales Agents in Global

11 CONCLUSION


12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Luseogliflozin in Global Market
Table 2. Top Luseogliflozin Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Luseogliflozin Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Luseogliflozin Revenue Share by Companies, 2017-2022
Table 5. Global Luseogliflozin Sales by Companies, (K Units), 2017-2022
Table 6. Global Luseogliflozin Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Luseogliflozin Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Luseogliflozin Product Type
Table 9. List of Global Tier 1 Luseogliflozin Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Luseogliflozin Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Luseogliflozin Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Luseogliflozin Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Luseogliflozin Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Luseogliflozin Sales (K Units), 2017-2022
Table 15. By Type - Global Luseogliflozin Sales (K Units), 2023-2028
Table 16. By Application – Global Luseogliflozin Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Luseogliflozin Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Luseogliflozin Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Luseogliflozin Sales (K Units), 2017-2022
Table 20. By Application - Global Luseogliflozin Sales (K Units), 2023-2028
Table 21. By Region – Global Luseogliflozin Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Luseogliflozin Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Luseogliflozin Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Luseogliflozin Sales (K Units), 2017-2022
Table 25. By Region - Global Luseogliflozin Sales (K Units), 2023-2028
Table 26. By Country - North America Luseogliflozin Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Luseogliflozin Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Luseogliflozin Sales, (K Units), 2017-2022
Table 29. By Country - North America Luseogliflozin Sales, (K Units), 2023-2028
Table 30. By Country - Europe Luseogliflozin Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Luseogliflozin Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Luseogliflozin Sales, (K Units), 2017-2022
Table 33. By Country - Europe Luseogliflozin Sales, (K Units), 2023-2028
Table 34. By Region - Asia Luseogliflozin Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Luseogliflozin Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Luseogliflozin Sales, (K Units), 2017-2022
Table 37. By Region - Asia Luseogliflozin Sales, (K Units), 2023-2028
Table 38. By Country - South America Luseogliflozin Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Luseogliflozin Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Luseogliflozin Sales, (K Units), 2017-2022
Table 41. By Country - South America Luseogliflozin Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Luseogliflozin Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Luseogliflozin Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Luseogliflozin Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Luseogliflozin Sales, (K Units), 2023-2028
Table 46. Taisho Toyama Corporate Summary
Table 47. Taisho Toyama Luseogliflozin Product Offerings
Table 48. Taisho Toyama Luseogliflozin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Novartis Corporate Summary
Table 50. Novartis Luseogliflozin Product Offerings
Table 51. Novartis Luseogliflozin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Mitsubishi Tanabe Pharma Corporate Summary
Table 53. Mitsubishi Tanabe Pharma Luseogliflozin Product Offerings
Table 54. Mitsubishi Tanabe Pharma Luseogliflozin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. CR Double-Crane Corporate Summary
Table 56. CR Double-Crane Luseogliflozin Product Offerings
Table 57. CR Double-Crane Luseogliflozin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Luseogliflozin Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 59. Global Luseogliflozin Capacity Market Share of Key Manufacturers, 2020-2022
Table 60. Global Luseogliflozin Production by Region, 2017-2022 (K Units)
Table 61. Global Luseogliflozin Production by Region, 2023-2028 (K Units)
Table 62. Luseogliflozin Market Opportunities & Trends in Global Market
Table 63. Luseogliflozin Market Drivers in Global Market
Table 64. Luseogliflozin Market Restraints in Global Market
Table 65. Luseogliflozin Raw Materials
Table 66. Luseogliflozin Raw Materials Suppliers in Global Market
Table 67. Typical Luseogliflozin Downstream
Table 68. Luseogliflozin Downstream Clients in Global Market
Table 69. Luseogliflozin Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Luseogliflozin Segment by Type
Figure 2. Luseogliflozin Segment by Application
Figure 3. Global Luseogliflozin Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Luseogliflozin Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Luseogliflozin Revenue, 2017-2028 (US$, Mn)
Figure 7. Luseogliflozin Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Luseogliflozin Revenue in 2021
Figure 9. By Type - Global Luseogliflozin Sales Market Share, 2017-2028
Figure 10. By Type - Global Luseogliflozin Revenue Market Share, 2017-2028
Figure 11. By Type - Global Luseogliflozin Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Luseogliflozin Sales Market Share, 2017-2028
Figure 13. By Application - Global Luseogliflozin Revenue Market Share, 2017-2028
Figure 14. By Application - Global Luseogliflozin Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Luseogliflozin Sales Market Share, 2017-2028
Figure 16. By Region - Global Luseogliflozin Revenue Market Share, 2017-2028
Figure 17. By Country - North America Luseogliflozin Revenue Market Share, 2017-2028
Figure 18. By Country - North America Luseogliflozin Sales Market Share, 2017-2028
Figure 19. US Luseogliflozin Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Luseogliflozin Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Luseogliflozin Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Luseogliflozin Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Luseogliflozin Sales Market Share, 2017-2028
Figure 24. Germany Luseogliflozin Revenue, (US$, Mn), 2017-2028
Figure 25. France Luseogliflozin Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Luseogliflozin Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Luseogliflozin Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Luseogliflozin Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Luseogliflozin Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Luseogliflozin Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Luseogliflozin Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Luseogliflozin Sales Market Share, 2017-2028
Figure 33. China Luseogliflozin Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Luseogliflozin Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Luseogliflozin Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Luseogliflozin Revenue, (US$, Mn), 2017-2028
Figure 37. India Luseogliflozin Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Luseogliflozin Revenue Market Share, 2017-2028
Figure 39. By Country - South America Luseogliflozin Sales Market Share, 2017-2028
Figure 40. Brazil Luseogliflozin Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Luseogliflozin Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Luseogliflozin Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Luseogliflozin Sales Market Share, 2017-2028
Figure 44. Turkey Luseogliflozin Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Luseogliflozin Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Luseogliflozin Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Luseogliflozin Revenue, (US$, Mn), 2017-2028
Figure 48. Global Luseogliflozin Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Luseogliflozin by Region, 2021 VS 2028
Figure 50. Luseogliflozin Industry Value Chain
Figure 51. Marketing Channels